These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 4372399

  • 1. Structure of the mouse mammary tumor virus: characterization of bald particles.
    Cardiff RD, Puentes MJ, Teramoto YA, Lund JK.
    J Virol; 1974 Nov; 14(5):1293-303. PubMed ID: 4372399
    [Abstract] [Full Text] [Related]

  • 2. Structure of the mouse mammary tumor virus: polypeptides and glycoproteins.
    Teramoto YA, Puentes MJ, Young LJ, Cardiff RD.
    J Virol; 1974 Feb; 13(2):411-8. PubMed ID: 4359300
    [Abstract] [Full Text] [Related]

  • 3. The polypeptide composition of mouse mammary tumor virus.
    Dickson C, Skehel JJ.
    Virology; 1974 Apr; 58(2):387-95. PubMed ID: 4362427
    [No Abstract] [Full Text] [Related]

  • 4. Polypeptides of the mouse mammary tumor virus. I. Characterization of two group-specific antigens.
    Sarkar NH, Dion AS.
    Virology; 1975 Apr; 64(2):471-91. PubMed ID: 49121
    [No Abstract] [Full Text] [Related]

  • 5. Expression and disposition of the murine mammary tumor virus (MuMTV) envelope gene products by murine mammary tumor cells.
    Sarkar NH, Racevskis J.
    Virology; 1983 Apr 15; 126(1):279-300. PubMed ID: 6302986
    [Abstract] [Full Text] [Related]

  • 6. The effects of 2-deoxyglucose and tunicamycin on the biosynthesis of the murine mammary tumor virus proteins, and on the assembly and release of the virus.
    Sarkar NH.
    Virology; 1986 Apr 30; 150(2):419-38. PubMed ID: 3008416
    [Abstract] [Full Text] [Related]

  • 7. Mice with spontaneous mammary tumors develop type-specific neutralizing and cytotoxic antibodies against the mouse mammary tumor virus envelope protein gp52.
    Schochetman G, Arthur LO, Long CW, Massey RJ.
    J Virol; 1979 Oct 30; 32(1):131-9. PubMed ID: 94356
    [Abstract] [Full Text] [Related]

  • 8. Detection and characterization of mouse mammary tumor virus cell surface antigens: estimation of antigen abundance by protein A assay.
    Callis AH, Ritzi EM.
    J Virol; 1980 Sep 30; 35(3):876-87. PubMed ID: 6252344
    [Abstract] [Full Text] [Related]

  • 9. The structure of the mouse mammary tumor virus: isolation and characterization of the core.
    Teramoto YA, Cardiff RD, Lund JK.
    Virology; 1977 Mar 30; 77(1):135-48. PubMed ID: 65834
    [No Abstract] [Full Text] [Related]

  • 10. Precursor-product relationship between nonglycosylated polypeptides of A and B particles of mouse mammary tumor virus.
    Tanaka H.
    Virology; 1977 Feb 30; 76(2):835-50. PubMed ID: 65829
    [No Abstract] [Full Text] [Related]

  • 11. Radioimmunoassays for the 36,000-dalton glycoprotein of murine mammary tumor viruses demonstrate type, group, and interspecies determinants.
    Teramoto YA, Schlom J.
    J Virol; 1979 Aug 30; 31(2):334-40. PubMed ID: 90170
    [Abstract] [Full Text] [Related]

  • 12. The major polypeptides of the murine-mammary-tumor virus isolated by plant-lectin affinity chromatography.
    Westenbrink F, Koornstra W, Bentvelzen P.
    Eur J Biochem; 1977 Jun 01; 76(1):85-90. PubMed ID: 195815
    [Abstract] [Full Text] [Related]

  • 13. Processing and amino acid sequence analysis of the mouse mammary tumor virus env gene product.
    Arthur LO, Copeland TD, Oroszlan S, Schochetman G.
    J Virol; 1982 Feb 01; 41(2):414-22. PubMed ID: 6281457
    [Abstract] [Full Text] [Related]

  • 14. Immunochemical characterization of two major polypeptides from murine mammary tumor virus.
    Parks WP, Howk RS, Scolnick EM, Oroszlan S, Gilden RV.
    J Virol; 1974 Jun 01; 13(6):1200-10. PubMed ID: 4364896
    [Abstract] [Full Text] [Related]

  • 15. Biosynthesis of Rauscher leukemia viral proteins.
    Naso RB, Arcement LJ, Arlinghaus RB.
    Cell; 1975 Jan 01; 4(1):31-6. PubMed ID: 803875
    [Abstract] [Full Text] [Related]

  • 16. Strain-specific markers for the major structural proteins of highly oncogenic murine mammary tumor viruses by tryptic peptide analyses.
    Gautsch JW, Lerner R, Howard D, Teramoto YA, Schlom J.
    J Virol; 1978 Sep 01; 27(3):688-99. PubMed ID: 212589
    [Abstract] [Full Text] [Related]

  • 17. Murine mammary tumor virus structural protein interactions: formation of oligomeric complexes with cleavable cross-linking agents.
    Racevskis J, Sarkar NH.
    J Virol; 1980 Sep 01; 35(3):937-48. PubMed ID: 6252348
    [Abstract] [Full Text] [Related]

  • 18. Isolation and characterization of two distinct types of HVJ (Sendai virus) spikes.
    Shimizu K, Shimizu YK, Koama T, Ishida N.
    Virology; 1974 Nov 01; 62(1):90-101. PubMed ID: 4370706
    [No Abstract] [Full Text] [Related]

  • 19. Structural components of mouse mammary tumor virus. II. Isolation and purification of virion polypeptides.
    Yagi MJ, Stutzman RE, Robertson BH, Compans RW.
    J Virol; 1978 May 01; 26(2):448-56. PubMed ID: 207897
    [Abstract] [Full Text] [Related]

  • 20. Impaired maturation of mouse mammary tumor virus precursor polypeptides in lymphoid leukemia cells, producing intracytoplasmic A particles and no extracellular B-type virions.
    Nusse R, van der Ploeg L, van Duijn L, Michalides R, Hilgers J.
    J Virol; 1979 Oct 01; 32(1):251-8. PubMed ID: 232176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.